Page last updated: 2024-09-05

sb 203580 and Atrophy

sb 203580 has been researched along with Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butters, KA; Cheng, J; Garovic, VD; Grande, JP; Gray, CE; Knudsen, BE; Lerman, LO; Lien, KR; Nath, KA; Simari, RD; Textor, SC; Wang, D; Warner, GM; Yin, P	1

Other Studies

1 other study(ies) available for sb 203580 and Atrophy

Article	Year
Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model. American journal of physiology. Renal physiology, 2013, Apr-01, Volume: 304, Issue:7 Topics: Animals; Atrophy; Chemokine CCL2; Chemokine CCL7; Disease Models, Animal; Fibrosis; Imidazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Nephrosclerosis; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, CCR2; Renal Artery Obstruction; Signal Transduction; Up-Regulation	2013

Article

Year

Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model.

American journal of physiology. Renal physiology, 2013, Apr-01, Volume: 304, Issue:7

Topics: Animals; Atrophy; Chemokine CCL2; Chemokine CCL7; Disease Models, Animal; Fibrosis; Imidazoles; Kidney; Male; Mice; Mice, Inbred C57BL; Nephrosclerosis; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, CCR2; Renal Artery Obstruction; Signal Transduction; Up-Regulation

2013